Product Details
Heart Type Fatty Acid Binding Protein Detection Reagent
(Immunofluorescence Chromatography) Clinical Comparison
H-FABP Overview
H-FABP is a small cytoplasmic protein mainly present in the
cytoplasm of cardiac muscle. When the heart muscle is damaged, it
is quickly released into the bloodstream, cleared from the plasma
by the kidneys, and then returned to normal. AMI starts to rise 30
minutes after onset, peaks about 6-8 hours, and returns to normal
20 hours later. The sensitivity of H-FABP in the early diagnosis of
AMI was much higher than that of MYO, CTN and CK-MB, and the
specificity was higher than that of MYO. H-FABP is more useful for
early diagnosis of chest pain within 3 hours.
H-FABP Performance Index
Detection range | sample size | Sample type | Test time |
2~120ng/mL | 60μl | Serum / plasma / whole blood | 15min |
H-FABP Clinical Significance
- Early diagnosis of acute myocardial infarction and indicators of
reinfarction
- Myocardial infarction size assessment
- Differential diagnosis and prognosis evaluation of acute coronary
heart disease (ACS)
- Valid index for evaluating the efficacy of myocardial reperfusion
- Severity and prognosis of heart failure
- Prognosis of pulmonary embolism (PE)
H-FABP Clinical comparison
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
Company Profile
Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is
located in Dingluan Industrial Zone, Changyuan City, Henan
Province. The company covers an area of about 100 acres and the
initial investment is about 200 million yuan. The company has a
scientific and complete management system, a purification workshop
of national standards, and a fully functional inspection center. On
this basis, the company will continue to invest in research and
development, accumulate technical strength, update manufacturing
equipment, improve production technology, improve inspection
technology, improve product quality, and provide customers with
safe and effective in vitro diagnostic products.
Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, immune series,
microbial series and other reagents and supporting instruments.
The company has always adhered to the core concept of “fast and
accurate, living up to life”, committed to providing society with
excellent products and services, and contributing to the cause of
human health.